Published in J Cell Sci on November 01, 2001
Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol (2008) 2.81
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev (2008) 2.45
Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A (2006) 2.15
A murine model of urinary tract infection. Nat Protoc (2009) 2.15
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother (2010) 2.05
Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog (2007) 2.01
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A (2012) 1.84
Uroplakins in urothelial biology, function, and disease. Kidney Int (2009) 1.79
Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol (2004) 1.69
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun (2012) 1.64
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One (2008) 1.54
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells. PLoS Pathog (2015) 1.47
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Structural basis of chaperone-subunit complex recognition by the type 1 pilus assembly platform FimD. EMBO J (2005) 1.42
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med (2013) 1.38
LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol (2007) 1.37
Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (2005) 1.35
Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect Immun (2007) 1.35
Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution. J Cell Biol (2006) 1.34
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28
A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol (2011) 1.26
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function. FEMS Microbiol Rev (2012) 1.26
Rab11a-dependent exocytosis of discoidal/fusiform vesicles in bladder umbrella cells. Proc Natl Acad Sci U S A (2008) 1.20
α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest (2014) 1.18
HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect Immun (2006) 1.11
Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors. Appl Environ Microbiol (2006) 1.11
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10
Urinary tract infections in women: etiology and treatment options. Int J Gen Med (2011) 1.08
Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. Infect Immun (2006) 1.06
Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol (2012) 1.02
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob Agents Chemother (2012) 1.02
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS One (2014) 0.93
Formation and maintenance of blood-urine barrier in urothelium. Protoplasma (2010) 0.92
Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect (2008) 0.90
Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. J Mol Biol (2009) 0.90
Synthetic polymer nanoparticles conjugated with FimH(A) from E. coli pili to emulate the bacterial mode of epithelial internalization. J Am Chem Soc (2012) 0.89
Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain. Infect Immun (2013) 0.88
Fluorescence resonance energy transfer (FRET)-based subcellular visualization of pathogen-induced host receptor signaling. BMC Biol (2009) 0.88
YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration. Infect Immun (2012) 0.88
Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J Infect Dis (2014) 0.87
Atomic force microscopy of Mammalian urothelial surface. J Mol Biol (2007) 0.87
MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells. Mol Biol Cell (2012) 0.87
Characteristics of the phagocytic cup induced by uropathogenic Escherichia coli. J Histochem Cytochem (2008) 0.84
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83
Assembly of a membrane receptor complex: roles of the uroplakin II prosequence in regulating uroplakin bacterial receptor oligomerization. Biochem J (2008) 0.83
What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli. Virulence (2012) 0.82
Catch-bond mechanism of the bacterial adhesin FimH. Nat Commun (2016) 0.82
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells. Infect Immun (2011) 0.82
Spatiotemporal expression of UPK3B and its promoter activity during embryogenesis and spermatogenesis. Histochem Cell Biol (2016) 0.82
Glycosylation of uroplakins. Implications for bladder physiopathology. Glycoconj J (2014) 0.80
Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer (2007) 0.80
Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract. J Biol Chem (2012) 0.80
Establishment and Characterization of UTI and CAUTI in a Mouse Model. J Vis Exp (2015) 0.80
The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli. J Bacteriol (2016) 0.79
Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection. Microbiol Spectr (2015) 0.79
SNX31: a novel sorting nexin associated with the uroplakin-degrading multivesicular bodies in terminally differentiated urothelial cells. PLoS One (2014) 0.79
Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection. PLoS One (2015) 0.78
Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions. Acta Crystallogr D Biol Crystallogr (2013) 0.78
Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques. Urolithiasis (2014) 0.78
Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. Microbiol Mol Biol Rev (2016) 0.78
Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation. Proc Natl Acad Sci U S A (2016) 0.77
Bacterial lysis liberates the neutrophil migration suppressor YbcL from the periplasm of uropathogenic Escherichia coli. Infect Immun (2014) 0.77
A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol (2016) 0.77
Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J Clin Invest (2016) 0.77
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer. Mol Ther Oncolytics (2016) 0.76
Who's really in control: microbial regulation of protein trafficking in the epithelium. Am J Physiol Cell Physiol (2013) 0.76
Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli. Sci Rep (2015) 0.76
Cystitis: from urothelial cell biology to clinical applications. Biomed Res Int (2014) 0.76
Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens (2016) 0.76
Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice. Pathog Dis (2014) 0.76
Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections. J Med Chem (2016) 0.75
Perspective: Adhesion Mediated Signal Transduction in Bacterial Pathogens. Pathogens (2016) 0.75
The multiple antibacterial activities of the bladder epithelium. Ann Transl Med (2017) 0.75
Sequential and compartmentalized action of Rabs, SNAREs, and MAL in the apical delivery of fusiform vesicles in urothelial umbrella cells. Mol Biol Cell (2016) 0.75
Decreased expression of uroplakin Ia is associated with colorectal cancer progression and poor survival of patients. Int J Clin Exp Pathol (2014) 0.75
Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes. PLoS One (2016) 0.75
Invasion of Host Cells and Tissues by Uropathogenic Bacteria. Microbiol Spectr (2016) 0.75
Surfaces Presenting α-Phenyl Mannoside Derivatives Enable Formation of Stable, High Coverage, Non-pathogenic Escherichia coli Biofilms against Pathogen Colonization. Biomater Sci (2015) 0.75
Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria. Microbiol Spectr (2015) 0.75
Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli. Front Cell Infect Microbiol (2016) 0.75
Role of renal urothelium in the development and progression of kidney disease. Pediatr Nephrol (2016) 0.75
Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease. Expert Opin Drug Discov (2017) 0.75
Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Ci Ji Yi Xue Za Zhi (2017) 0.75
A Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium. Infect Immun (2017) 0.75
Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell (1990) 12.13
Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell (2000) 6.93
Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell (1994) 6.54
Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell (1989) 6.49
NMR structure of the mouse prion protein domain PrP(121-231). Nature (1996) 6.37
Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol (1986) 5.96
Immunofluorescent staining of keratin fibers in cultured cells. Cell (1978) 4.25
Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 4.03
Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol (1984) 4.00
NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett (1997) 3.90
Keratin filaments of cultured human epidermal cells. Formation of intermolecular disulfide bonds during terminal differentiation. J Biol Chem (1978) 3.82
Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell (1982) 3.54
Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol (1982) 3.47
Keratin cytoskeletons in epithelial cells of internal organs. Proc Natl Acad Sci U S A (1979) 3.45
Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell (1976) 3.30
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci U S A (1995) 3.18
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest (1985) 3.03
Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci (1998) 2.78
Epidermal stem cells: properties, markers, and location. Proc Natl Acad Sci U S A (2000) 2.66
The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol (1983) 2.58
Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol (1984) 2.48
In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A (1996) 2.35
Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Science (1982) 2.28
Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet (1994) 2.19
Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J Biol Chem (2001) 2.19
Cultured epithelial cells of cornea, conjunctiva and skin: absence of marked intrinsic divergence of their differentiated states. Nature (1977) 2.17
Methyl 4-mercaptobutyrimidate as a cleavable cross-linking reagent and its application to the Escherichia coli 30S ribosome. Biochemistry (1973) 2.14
Intrinsic and extrinsic regulation of the differentiation of skin, corneal and esophageal epithelial cells. Cell (1980) 2.11
Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol (2000) 2.11
Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem (1994) 2.07
The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J Cell Biol (1986) 2.04
Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A (1998) 2.02
Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry (1999) 1.93
Acidic and basic hair/nail ("hard") keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to "soft" keratins. J Cell Biol (1986) 1.91
Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem (1990) 1.88
Prion protein NMR structure and species barrier for prion diseases. Proc Natl Acad Sci U S A (1997) 1.86
Epidermal stem cells. J Invest Dermatol (1983) 1.86
Circularly permuted variants of the green fluorescent protein. FEBS Lett (1999) 1.85
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol (1983) 1.76
The fibrillar substructure of keratin filaments unraveled. J Cell Biol (1983) 1.75
Redox properties of protein disulfide isomerase (DsbA) from Escherichia coli. Protein Sci (1993) 1.75
The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat Biotechnol (1998) 1.71
Expression of epidermal keratins and filaggrin during human fetal skin development. J Cell Biol (1985) 1.68
Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol (1994) 1.67
Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res (1999) 1.62
In vitro growth and differentiation of rabbit bulbar, fornix, and palpebral conjunctival epithelia. Implications on conjunctival epithelial transdifferentiation and stem cells. Invest Ophthalmol Vis Sci (1993) 1.61
An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol (1993) 1.58
Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells. J Biol Chem (1995) 1.56
Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci (1993) 1.56
A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc Natl Acad Sci U S A (1998) 1.55
Characterization of Escherichia coli thioredoxin variants mimicking the active-sites of other thiol/disulfide oxidoreductases. Protein Sci (1998) 1.53
The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol (1983) 1.48
The use of antikeratin antiserum as a diagnostic tool: thymoma versus lymphoma. Hum Pathol (1980) 1.48
A single dipeptide sequence modulates the redox properties of a whole enzyme family. Fold Des (1998) 1.48
Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci U S A (1994) 1.46
Primary uroepithelial cultures. A model system to analyze umbrella cell barrier function. J Biol Chem (1999) 1.43
Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol (1999) 1.42
Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett (1997) 1.42
Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann N Y Acad Sci (1985) 1.39
Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem (2000) 1.38
Relative proliferative rates of limbal and corneal epithelia. Implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing keratinocytes. Invest Ophthalmol Vis Sci (1991) 1.38
Cornea-specific expression of K12 keratin during mouse development. Curr Eye Res (1993) 1.36
In vivo control of redox potential during protein folding catalyzed by bacterial protein disulfide-isomerase (DsbA). J Biol Chem (1993) 1.35
Dimerization of beta B2-crystallin: the role of the linker peptide and the N- and C-terminal extensions. Protein Sci (1994) 1.34
Interaction of trichohyalin with intermediate filaments: three immunologically defined stages of trichohyalin maturation. J Invest Dermatol (1992) 1.34
Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest (1995) 1.33
Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. J Biol Chem (1994) 1.33
Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene (2001) 1.33
Importance of redox potential for the in vivo function of the cytoplasmic disulfide reductant thioredoxin from Escherichia coli. J Biol Chem (1999) 1.32
Cells within the bulge region of mouse hair follicle transiently proliferate during early anagen: heterogeneity and functional differences of various hair cycles. Differentiation (1994) 1.32
Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J (2001) 1.31
Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology (1999) 1.31
Random circular permutation of DsbA reveals segments that are essential for protein folding and stability. J Mol Biol (1999) 1.31
Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: a closed "twisted ribbon" structure. J Mol Biol (1995) 1.31
Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmology (1990) 1.29
Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol (1990) 1.27
Hair follicle stem cells: their location, role in hair cycle, and involvement in skin tumor formation. J Invest Dermatol (1993) 1.26
Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat Struct Biol (1999) 1.26
Assessing the differentiation state of cultured bovine urothelial cells: elevated synthesis of stratification-related K5 and K6 keratins and persistent expression of uroplakin I. J Cell Sci (1990) 1.25
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A (2000) 1.25
Comparison of commercially available target enrichment methods for next-generation sequencing. J Biomol Tech (2013) 1.25
Label-retaining cells are preferentially located in fornical epithelium: implications on conjunctival epithelial homeostasis. Invest Ophthalmol Vis Sci (1995) 1.24
Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR. Nat Struct Biol (1999) 1.23
Identification of mouse mammary epithelial cells by immunofluorescence with rabbit and guinea pig antikeratin antisera. Proc Natl Acad Sci U S A (1981) 1.23
Bacterial protein disulfide isomerase: efficient catalysis of oxidative protein folding at acidic pH. Biochemistry (1993) 1.22